Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
Palbociclib Impurity 75 REF: 4Z-P-196082	- - -	To inquire	Fri 27 Dec 24
Palbociclib Impurity 44 REF: 4Z-P-196051CAS: 82205-58-1	- - -	To inquire	Fri 27 Dec 24
Carfilzomib Impurity 10 REF: 4Z-C-121013	- - -	To inquire	Fri 27 Dec 24
Tamoxifen-d5 REF: 4Z-T-018	- - -	To inquire	Fri 27 Dec 24
Fulvestrant Impurity 1 REF: 4Z-F-3114	- - -	To inquire	Fri 27 Dec 24
Bestatin Impurity 16 HCl REF: 4Z-B-119019	- - -	To inquire	Fri 27 Dec 24
Bestatin Impurity 27 HCl REF: 4Z-B-119030	- - -	To inquire	Fri 27 Dec 24
Gimeracil Impurity 9 REF: 4Z-G-047011	- - -	To inquire	Fri 27 Dec 24
Leuprorelin (Leuprolide)-d10 Trifluoroacetic Acid Salt REF: 4Z-PL-4114CAS: 53714-56-0	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 24 REF: 4Z-O-032026	- - -	To inquire	Fri 27 Dec 24
Carfilzomib Impurity 69 REF: 4Z-C-121072CAS: 1960444-14-7	- - -	To inquire	Fri 27 Dec 24
Nintedanib Impurity 67 REF: 4Z-N-066085CAS: 350-46-9	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 59 REF: 4Z-O-032064CAS: 16859-59-9	- - -	To inquire	Fri 27 Dec 24
Abiraterone Impurity 21 REF: 4Z-A-8261	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 69 REF: 4Z-O-032074CAS: 477535-39-0	- - -	To inquire	Fri 27 Dec 24
Carfilzomib Impurity 67 REF: 4Z-C-121070CAS: 868539-99-5	- - -	To inquire	Fri 27 Dec 24
Palbociclib Impurity 10 REF: 4Z-P-196014CAS: 2206135-30-8	- - -	To inquire	Fri 27 Dec 24
N- Desmethyl Tamoxifen (E/Z mixture) REF: 4Z-T-0131	- - -	To inquire	Fri 27 Dec 24
Nintedanib Impurity 39 REF: 4Z-N-066057CAS: 121-95-9	- - -	To inquire	Fri 27 Dec 24
Fulvestrant Impurity 17 REF: 4Z-F-3125	- - -	To inquire	Fri 27 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Palbociclib Impurity 75

Ref: 4Z-P-196082

Palbociclib Impurity 44

Ref: 4Z-P-196051

Carfilzomib Impurity 10

Ref: 4Z-C-121013

Tamoxifen-d5

Ref: 4Z-T-018

Fulvestrant Impurity 1

Ref: 4Z-F-3114

Bestatin Impurity 16 HCl

Ref: 4Z-B-119019

Bestatin Impurity 27 HCl

Ref: 4Z-B-119030

Gimeracil Impurity 9

Ref: 4Z-G-047011

Leuprorelin (Leuprolide)-d10 Trifluoroacetic Acid Salt

Ref: 4Z-PL-4114

Olaparib Impurity 24

Ref: 4Z-O-032026

Carfilzomib Impurity 69

Ref: 4Z-C-121072

Nintedanib Impurity 67

Ref: 4Z-N-066085

Olaparib Impurity 59

Ref: 4Z-O-032064

Abiraterone Impurity 21

Ref: 4Z-A-8261

Olaparib Impurity 69

Ref: 4Z-O-032074

Carfilzomib Impurity 67

Ref: 4Z-C-121070

Palbociclib Impurity 10

Ref: 4Z-P-196014

N- Desmethyl Tamoxifen (E/Z mixture)

Ref: 4Z-T-0131

Nintedanib Impurity 39

Ref: 4Z-N-066057

Fulvestrant Impurity 17

Ref: 4Z-F-3125